manipulation over the Opportunities opened up with human genetic engineering need to be regulated global to avoid exploitation
Restoring the body with gene therapy.
Tap on icon for description, click on resource name for more details.
Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors
Gene therapy innovation leaders developing platforms to treat severe genetic disorders and cellular aging
Company that uses genome editing technologies to deliver regenerative medicine solutions
Company that provides essential products and services to help pharmaceutical and biotechnology companies
Company developing transformative gene-based medicines for serious human diseases
Eagle Genomics innovates at the intersection of biology, data sciences and bioinformatics
Company that develops novel medicinal products intended to restore health and prevent bacterial infections
Biotechnology company focused on developing liver directed gene therapies for a range of diseases
Gene editing company that designs & engineers genetically-modified cells, applying them to advance human health
Company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies
Gene Therapy Blog Posts
Breakthrough gene therapy offers cure for a rare bleeding disorder heamophilia
BBC - 21-Jul-2022
Trial results were positive but cautioned the use until proven safe and effectiveRead more...
HTR in Drosophila somatic cells using nikase and CRISPR genetic editing tools
Genetic Engineering & Biotechnology News (GEN) - 05-Jul-2022
CRISPR genetic editing tools may be helpful in genetic repairRead more...
Lifespan of middle-aged mice increased by a third with telomerase gene therapy
CISION PR Newswire - 19-May-2022
Treatment used proprietary CMV vector which is able to deliver multiple genes into the nucleusRead more...
Viral-vector gene therapies could unlock healthy life extension in humans
Lifespan.io (LEAF) - 12-May-2022
Lifespan of mice greatly extended even when treatment only started at the equivalent of 56 years oldRead more...
Verve Therapeutics' gene editing therapy may cure heart attacks once and for all
Bloomberg - 06-May-2022
Trials underway to test the safety, but affordability and acceptance of gene therapy are major concernsRead more...